Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ARIAD PHARMACEUTICALS INC
| Metric | ARIAD PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 49 / 100 |
| Revenue (latest) | $119M |
| Net income (latest) | −$231M |
| Operating margin | −182.9% |
| Net margin | −194.6% |
| Return on equity | 224.1% |
| Return on assets | −42.3% |
| Return on capital (ROCE) | −52.4% |
| Debt / equity | — |
| Revenue growth (YoY) | 12.7% |
| Altman Z″ (distress) | -9.74 |
| Accruals / assets | −13.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.